Walder Wyss advised Sparta Commodities, a specialist in real-time intelligence for commodity traders, in connection with its USD 42m Series-B financing round. The context One Peak led the capital round in question, with support from
Loyens & Loeff advised Swedish listed Alfa Laval as Swiss counsel on a binding put-option agreement to acquire the Fives Cryogenics business unit, part of the French Fives Group, for a total fixed purchase price
Baptiste Favez (pictured) joined Altenburger, effective April 1st, 2025. A dispute resolution expert, Favez represents both national and international clients in the fields of construction and real estate law, where he is a certified specialist. He
Niederer Kraft Frey (NKF) acted as Swiss counsel to German battery manufacturer Varta in connection with the successful completion of a financial restructuring under the German StaRUG. Pursuant to the transaction, Varta secures EUR 60 million
French automotive distributor BPM completed the acquisition of Renens-based Groupe Leuba. In connection with the deal, Borel & Barbey represented the buyer, while Kellerhals Carrard advised the shareholders of Groupe Leuba. The parties Headquartered in
On April 1st 2025, Déborah Carlson Burkart (pictured) joined Eversheds Sutherland as the firm’s new Of-Counsel in Bern, moving from Wernli Rechtsanwälte. Burkart’s legal experience spans the areas of corporate law, corporate
Kellerhals Carrard advised Swiss clinical-stage biotechnology company MoonLake Immunotherapeutics on its agreement with American venture lending specialist Hercules Capital for up to $500 million in non-dilutive capital, with an initial $75 million drawn at closing. Pursuant to
Kellerhals Carrard advised Bloom Biorenewables in connection with the closing of its CHF 13M Series A financing round. The investors Anaïs Ventures and Valquest Partners led the capital round in question, with further participation
Advestra advised Banque Cantonale de Genève on its inaugural EUR-Bonds of EUR 500 million. The issuance Banque Cantonale de Genève debuted on the EUR-bonds market, issuing bonds in the aggregate prin
As of March 2025, Ferdinand Winter (pictured) has been appointed General Counsel of Ten23 health, a Swiss pharmaceutical contract development and manufacturing organization. Moving from Hansa Biopharma, Sweden, Ferdinand will be responsible for establishing and leading
